In this interview, James Corbett offers a very useful “big picture” on the layers of deception and systems of control embedded in society. There is no place to hide.
ImmunaBand Bracelet Is a Wearable Vaccine Passport
If we adopt this tool, then it will be so great because everybody can see your vaccine status and thus more easily discriminate against those who have not been vaccinated.
“Wear this bracelet to work, to restaurants, and to let people know your commitment to overcoming this disease through your completion of the vaccination series,” the company says on its website. “The bracelet is also a symbol of your commitment to safety — for yourself and for others.”
Why Are Gates and Pentagon Releasing “Gene Edited” (GMO) Mosquitoes in Florida Keys?
Topic Editors of Frontiers in Pharmacology for the Special Issue “Treating COVID-19 with Currently Available Drugs” Resign in Protest
Four Guest Editors resigned over the egregious treatment of two manuscripts (“REVIEW OF THE EMERGING EVIDENCE DEMONSTRATING THE EFFICACY OF IVERMECTIN IN THE PROPHYLAXIS AND TREATMENT OF COVID-19” and the original research manuscript “HOSPITALIZED COVID-19 PATIENTS TREATED WITH CELECOXIB AND HIGH DOSE FAMOTIDINE ADJUVANT THERAPY SHOW SIGNIFICANT CLINICAL RESPONSES”). Both papers received favorable peer reviews, and yet the papers sat for months unaddressed and then were ultimately rejected. A strong case could be made many COVID-19 patients died unnecessarily due to the delays and ultimate rejection of these papers. The letter concludes: “On behalf of our peers, our institutions, and our scientific and medical colleagues we cannot allow this precedent to remain unchallenged. In our opinion, these unfortunate events constitute gross editorial misconduct by ‘Frontiers’.” The full letter is available in the link below:
64 Days and Counting — Why Won’t the CDC Answer Our Questions?
The Children’s Health Defense Fund has published this excellent resource for understanding a range of discrepancies and unanswered questions, including these two critical issues:
CDC reduces Ct threshold for COVID testing but only for the vaccinated
As of April 26, 2021 more than 9,245 COVID cases had been reported in the fully vaccinated, known as “breakthrough cases.” The CDC recently recommended reducing the RT-PCR Ct value to 28 cycles when testing fully vaccinated people for COVID.
The lower threshold would result in a decrease in positive breakthrough cases, calling into question COVID vaccine efficacy data.
Dr. Fauci recommends a Ct value of 35. Globally, the accepted cut-off for Ct value for COVID ranges between 35 and 40, depending on instructions from manufacturers of testing equipment.
According to the Indian Council of Medical Research (ICMR), a patient is considered positive for COVID if the Ct value is below 35. In other words, if the virus is detectable after 35 cycles or earlier, then the patient is considered positive.
“If the benchmark were to be lowered to 24 it would mean that Ct values in the range 25-34 would not be considered positive. A benchmark of 35, therefore, means that more patients would be considered positive than we would get if the benchmark were 24.”
We asked the CDC to explain why it changed the recommendations for COVID testing in vaccinated patients, the impact this will have on reports of breakthrough COVID cases and why the agency does not apply one RT-PCR testing standard for testing, regardless of vaccination status.
CDC stops counting all breakthrough cases (COVID infected among the vaccinated)
Federal health officials this month decided to limit how they monitor vaccinated people infected with COVID, drawing concern from some scientists who said the missing data could hinder scientists’ ability to investigate why and how breakthrough cases happen, Bloomberg reported.
Every Friday, the CDC posts the number of breakthrough cases in fully vaccinated individuals on its website. On May 7, the CDC announced it will transition to reporting only patients with COVID breakthrough infection who were hospitalized or died to “help maximize the quality of the data collected on cases of greatest clinical and public health importance.”
The change in reporting, which takes effect May 14, will reduce the number of breakthrough cases reported.
We asked the CDC to explain why the agency altered the way it counts COVID breakthrough cases, to explain the effect this will have on breakthrough numbers and how the CDC can monitor vaccine efficacy if it excludes breakthrough cases of COVID that do not result in hospitalization or death.